Markets:

Overview

News

Currencies

International

Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

5.495 +0.215 (+4.07%)

Streaming Delayed Price Updated: 12:54 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Unicycive Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

These stocks are moving in today's after hours session ↗

June 02, 2025

Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Shalabh Gupta, CEO of Unicycive Therapeutics Inc. (NASDAQ: UNCY), to Present at NobleCon20

November 19, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 11, 2024

Via Benzinga

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

September 20, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Where Unicycive Therapeutics Stands With Analysts ↗

August 16, 2023

Via Benzinga

Analyst Expectations for Unicycive Therapeutics's Future ↗

July 19, 2023

Via Benzinga

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

September 16, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 19, 2024

Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!

Via InvestorPlace

Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday ↗

July 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 22, 2024

Via Benzinga

UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024 ↗

May 13, 2024

UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023 ↗

March 28, 2024

UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 14, 2024

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 07, 2024

Via Benzinga

Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 23, 2024

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.

Via Benzinga

Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2024

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 22, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers worth knowing about on Monday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 23, 2023

Via Benzinga

The 7 Most Undervalued Penny Stocks to Buy in October 2023 ↗

October 06, 2023

Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well.

Via InvestorPlace

Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD

September 06, 2023

Appointment adds decades of drug development experience from a seasoned executive

From Unicycive Therapeutics, Inc.

Via GlobeNewswire

Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series

August 29, 2023

From Unicycive Therapeutics, Inc.

Via GlobeNewswire

Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update

August 14, 2023

From Unicycive Therapeutics, Inc.

Via GlobeNewswire

CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

July 21, 2023

Via ACCESSWIRE

60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

July 21, 2023

Via ACCESSWIRE

Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference

July 20, 2023

From Unicycive Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.